249 related articles for article (PubMed ID: 33150144)
1. The Impact of Prostate Cancer Treatment on Quality of Life: A Narrative Review with a Focus on Randomized Data.
Taylor JM; Chen VE; Miller RC; Greenberger BA
Res Rep Urol; 2020; 12():533-546. PubMed ID: 33150144
[TBL] [Abstract][Full Text] [Related]
2. Survival and Complications Following Surgery and Radiation for Localized Prostate Cancer: An International Collaborative Review.
Wallis CJD; Glaser A; Hu JC; Huland H; Lawrentschuk N; Moon D; Murphy DG; Nguyen PL; Resnick MJ; Nam RK
Eur Urol; 2018 Jan; 73(1):11-20. PubMed ID: 28610779
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
[TBL] [Abstract][Full Text] [Related]
4. Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate.
Walsh PC
J Urol; 2000 Jun; 163(6):1802-7. PubMed ID: 10799186
[TBL] [Abstract][Full Text] [Related]
5. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.
Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849
[TBL] [Abstract][Full Text] [Related]
6. Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
Nair B; Wilt T; MacDonald R; Rutks I
Cochrane Database Syst Rev; 2002; (1):CD003506. PubMed ID: 11869665
[TBL] [Abstract][Full Text] [Related]
7. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
[TBL] [Abstract][Full Text] [Related]
8. Patient-reported Outcomes and Late Toxicity After Postprostatectomy Intensity-modulated Radiation Therapy.
Akthar AS; Liao C; Eggener SE; Liauw SL
Eur Urol; 2019 Nov; 76(5):686-692. PubMed ID: 31113644
[TBL] [Abstract][Full Text] [Related]
9. Quality of Life-Focused Decision-Making for Prostate Cancer.
Shevach J; Weiner A; Morgans AK
Curr Urol Rep; 2019 Aug; 20(10):57. PubMed ID: 31468212
[TBL] [Abstract][Full Text] [Related]
10. [Preoperative assessment of patient candidate to prostate cancer surgery].
Beauval JB; Mazerolles M; Salomon L; Soulié M
Prog Urol; 2015 Nov; 25(15):947-65. PubMed ID: 26519962
[TBL] [Abstract][Full Text] [Related]
11. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes.
Boorjian SA; Eastham JA; Graefen M; Guillonneau B; Karnes RJ; Moul JW; Schaeffer EM; Stief C; Zorn KC
Eur Urol; 2012 Apr; 61(4):664-75. PubMed ID: 22169079
[TBL] [Abstract][Full Text] [Related]
12. Postoperative radiation therapy for pathologically advanced prostate cancer after radical prostatectomy.
Stephenson AJ; Bolla M; Briganti A; Cozzarini C; Moul JW; Roach M; van Poppel H; Zietman A
Eur Urol; 2012 Mar; 61(3):443-51. PubMed ID: 22036777
[TBL] [Abstract][Full Text] [Related]
13. Clarifying uncertainty regarding detection and treatment of early-stage prostate cancer.
Wilt TJ
Semin Urol Oncol; 2002 Feb; 20(1):10-7. PubMed ID: 11828353
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in active surveillance and radical prostatectomy for low-risk prostate cancer: a prospective observational study (HAROW - Hormonal therapy, Active Surveillance, Radiation, Operation, Watchful Waiting).
Ansmann L; Winter N; Ernstmann N; Heidenreich A; Weissbach L; Herden J
BJU Int; 2018 Sep; 122(3):401-410. PubMed ID: 29603553
[TBL] [Abstract][Full Text] [Related]
15. Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.
Matta R; Chapple CR; Fisch M; Heidenreich A; Herschorn S; Kodama RT; Koontz BF; Murphy DG; Nguyen PL; Nam RK
Eur Urol; 2019 Mar; 75(3):464-476. PubMed ID: 30573316
[TBL] [Abstract][Full Text] [Related]
16. Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions.
Greenberger BA; Chen VE; Den RB
Front Oncol; 2019; 9():1273. PubMed ID: 31850194
[TBL] [Abstract][Full Text] [Related]
17. Conventional treatments of localized prostate cancer.
Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
[TBL] [Abstract][Full Text] [Related]
18. Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.
Hampson LA; Cowan JE; Zhao S; Carroll PR; Cooperberg MR
Eur Urol; 2015 Sep; 68(3):480-6. PubMed ID: 25656807
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
